Overview

• The families met Health Secretary Wes Streeting on June 9 to demand the identities of all staff who treated Calocane before the Nottingham attacks.
• Valdo Calocane was diagnosed with paranoid schizophrenia and sectioned four times between 2020 and 2022 but was not compelled to take long-acting antipsychotic medication due to needle aversion.
• Three independent reviews, including one by the Care Quality Commission, documented serious failings in his care but omitted practitioners’ names.
• Nottinghamshire Healthcare NHS Trust and NHS England have accepted every recommendation from the CQC and NHS England-commissioned reviews into Calocane’s treatment.
• The families have criticized trust chief executive Ifti Majid for providing vague and defensive correspondence and lodged a complaint with the IOPC over an offensive encounter with one of its regional directors.